HealthcarePress Releases

Healthcare Distribution Market Size to Worth Around USD 1,380 billion by 2030

Share This Article

global healthcare distribution market was evaluated at USD 810 billion in 2020 and is speculated to accrue USD 1,380 billion by 2030, growing at 7.8% CAGR between 2021-2030.

Latest Research Study on ” healthcare distribution Market – Global Industry Analysis, Market Size, Share, Growth, Trends, Region Outlook, And Segment Forecasts, 2021 – 2030″.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1259

This research report evaluates the healthcare distribution market on a global and regional level. It offers a thorough analysis of the market revenue status, growth, future trends, and forecast of the global healthcare distribution market for the period from 2017 to 2030.

Growth Factors

Factors such as rising incidence of chronic diseases and rapid progress of medical devices industry are driving the growth of healthcare distribution market. The frequency of chronic diseases has risen quickly in past few years due to increasing geriatric population globally. As per the WHO data, the prevalence of chronic disease will surge to 57% by 2021. This growth is expected to be the most substantial in the developing nations. A suitable healthcare distribution structure is therefore essential around the world, and has become a requirement. A synchronized and robust healthcare response is essential in every part of the world. Chronic diseases are some of the most rampant and expensive health conditions in the United States. Approximately half of all American people suffer from a minimum of one chronic ailment, and the count is growing. Internationally, almost one in three of all grownups suffer from multiple chronic conditions (MCCs) which are among the largest reason of the demise in the world.

The medical device business is poised for firm growth, with worldwide annual sales prediction to rise by over 5% a year and reach nearly US$800 billion by 2030. These estimates reflect growing demand for innovative new devices (like wearables) and services (like health data). This is majorly due to increasing prevalence of lifestyle diseases and high economic growth in emerging markets – particularly China and India.

Market Report Scope

Report Highlights Details
Market Size USD 1,380 Billion by 2030
Growth Rate CAGR of 7.8% From 2021 to 2030
Base Year 2020
Forecast Period 2021 to 2030
Segments Covered Product, End-Users
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, Latin America

For More Information or Customization Before Buying, Visit @ https://www.precedenceresearch.com/customization/1259

This report enables readers to make important decisions with regard to their business, with the help of a wealth of Information enclosed in the study. The report also provides the compound annual growth rate (CAGR) of the global healthcare distribution market for the forecast period of 2021–2030. This data can help readers interpret quantitative growth aspects of the global market during the forecast period. It presents a wealth of information on key market dynamics, including drivers, market trends, and challenges, as well as the structure of the global market across the globe.

The report analyzes the historical and present-day scenario of the global healthcare distribution market to accurately gauge its growth potential. The study presents detailed information about important growth factors, restraints, and key trends that are creating the landscape for growth of the global market in order to identify opportunities for stakeholders.

Key Highlights

  • Among the product type segment, pharmaceuticals are expected to dominate the overall market. Formation of new industrial facilitates by global pharmaceutical companies in new geographies, growing expenditure on pharmaceutical research and development activities, rising production of pharmaceutical preparations, and outsourcing of pharmaceutical manufacturing to the Asian nations is supporting the sector growth. Biopharmaceuticals are expected to advance at a significant CAGR in the estimate timeframe majorly due to increasing applications.
  • The retail pharmacies accounted for the largest revenue in the end user segment with more than 52.5% share in 2020. Implementation of programs to guarantee accessible health care for people in the US and other developed countries which subsequently increase the quantity of prescription is the major factor responsible for high market share of retail pharmacies.
  • McKesson Corporation accounted for the highest share of over 16% of the global healthcare distribution market.
  • The report covers data for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2020, North America dominated the global market with a market share of more than 38.5%.
  • U.S. accounted for the highest share in North America majorly due to the presence of major companies and early launch of latest products. Pharmaceutical distributors form the core of the healthcare ecosystem in North America.
  • Europe was the second prominent market majorly due to favorable reimbursement scenario and presence of latest healthcare infrastructure. The presence of skilled researchers in the European region is also expected to boost the demand for healthcare distribution market in the near future.
  • Asia Pacific is expected to grow at the highest CAGR of around 9% in the forecast period due to high investment by major market players.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1259

Competition Landscape

In the final section of the research report, Precedence Research provided the global healthcare distribution market structure and a detailed competition landscape to provide a dashboard view of key players operating in the global market along with their business strategies to report audiences. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the value chain of the market.

Some of the major players in the healthcare distribution market include:

  • AmerisourceBergen Corporation
  • McKesson Corporation
  • Medline Industries
  • Cardinal Health, Inc.
  • PHOENIX Group
  • Shanghai Pharmaceutical Group Co., Ltd.
  • Henry Schein Inc.
  • Owens & Minor, Inc.
  • Medline Industries
  • Rochester Drug Cooperative, Inc.

Market Segmentation

By Product Type

  • Biopharmaceutical
  • Pharmaceutical
  • Medical Device

By End User

  • Hospital Pharmacies
  • Retail Pharmacies
  • Other End Users

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

  • Market estimate for 2020
  • Average selling price (ASP) per region for specific product type
  • Filtrations and assortment of gathered data, to estimate the base year (2021) market size for the country
  • Gathering data from company websites, annual reports, white papers, financial reports, broker reports, investor presentations, and SEC filings
  • National government documents, statistical databases
  • News articles, press releases, and webcasts specific to companies operating in the market
  • Country wise analysis through internal and external proprietary databases, and relevant patent and regulatory databases
  • Determination of market penetration by country

Most Asked Questions –

What was the market size value of the healthcare distribution in 2020?

What is the expected market size by 2030?

What is the healthcare distribution market growth?

What are the key factors that positively influence market growth?

Who are the prominent players in the healthcare distribution market?

Why Buy this Report?

The purpose of Precedence Research’s healthcare distribution market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Healthcare Distribution Market, By Product

7.1. Healthcare Distribution Market, by Product Type, 2021-2030

7.1.1. Biopharmaceutical

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Pharmaceutical

7.1.2.1. Market Revenue and Forecast (2017-2030)

7.1.3. Medical Device

7.1.3.1. Market Revenue and Forecast (2017-2030)

7.1.4. Others

7.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Healthcare Distribution Market, By Application

8.1. Healthcare Distribution Market, by Application, 2021-2030

8.1.1. Hospital Pharmacies

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Retail Pharmacies

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Others

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Healthcare Distribution Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Forecast, by Product (2017-2030)

9.1.2. Market Revenue and Forecast, by Application (2017-2030)

9.1.3. U.S.

9.1.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.1.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.1.4. Rest of North America

9.1.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.1.4.2. Market Revenue and Forecast, by Application (2017-2030)

9.2. Europe

9.2.1. Market Revenue and Forecast, by Product (2017-2030)

9.2.2. Market Revenue and Forecast, by Application (2017-2030)

9.2.3. UK

9.2.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.2.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.2.4. Germany

9.2.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.2.4.2. Market Revenue and Forecast, by Application (2017-2030)

9.2.5. France

9.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

9.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

9.2.6. Rest of Europe

9.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

9.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

9.3. APAC

9.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.3.3. India

9.3.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.3.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.3.4. China

9.3.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.3.4.2. Market Revenue and Forecast, by Application (2017-2030)

9.3.5. Japan

9.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

9.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

9.3.6. Rest of APAC

9.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

9.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

9.4. MEA

9.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.4.2. Market Revenue and Forecast, by Application (2017-2030)

9.4.3. GCC

9.4.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.4.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.4.4. North Africa

9.4.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.4.4.2. Market Revenue and Forecast, by Application (2017-2030)

9.4.5. South Africa

9.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

9.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

9.4.6. Rest of MEA

9.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

9.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

9.5. Latin America

9.5.1. Market Revenue and Forecast, by Product (2017-2030)

9.5.2. Market Revenue and Forecast, by Application (2017-2030)

9.5.3. Brazil

9.5.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.5.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.5.4. Rest of LATAM

9.5.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.5.4.2. Market Revenue and Forecast, by Application (2017-2030)

Chapter 10. Company Profiles

10.1. AmerisourceBergen Corporation

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. McKesson Corporation

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. Medline Industries

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. Cardinal Health, Inc.

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. PHOENIX Group

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Shanghai Pharmaceutical Group Co., Ltd.

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. Henry Schein Inc.

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. Owens & Minor, Inc.

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3. Financial Performance

10.8.4. Recent Initiatives

10.9. Medline Industries

10.9.1. Company Overview

10.9.2. Product Offerings

10.9.3. Financial Performance

10.9.4. Recent Initiatives

10.10. Rochester Drug Cooperative, Inc.

10.10.1. Company Overview

10.10.2. Product Offerings

10.10.3. Financial Performance

10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1259

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

For Latest Update Follow Us:

https://www.linkedin.com/company/precedence-research/

https://www.facebook.com/precedenceresearch/

https://twitter.com/Precedence_R

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button